SPRO: Spero Therapeutics Inc. Stocks News on September 16, 2025

SPRO

Simply Wall St.

3 months ago

While institutions own 20% of Spero Therapeutics, Inc. (NASDAQ:SPRO), retail investors are its largest shareholders with 54% ownership

Spero Therapeutics Jumps as Oral Carbapenem Hits Phase 3 Milestone

SPRO

Insider Monkey

4 months ago

Spero Therapeutics Jumps as Oral Carbapenem Hits Phase 3 Milestone

SPRO

Zacks

4 months ago

SPRO Stock Soars 245% on GSK-Partnered UTI Drug Meeting Study Goal

Spero Therapeutics And 2 Other Promising Penny Stocks To Watch

SPRO

Simply Wall St.

4 months ago

Spero Therapeutics And 2 Other Promising Penny Stocks To Watch

SPRO

MT Newswires

4 months ago

Top Midday Gainers

SPRO

MT Newswires

4 months ago

Spero Therapeutics, GSK Say Phase 3 Trial of Oral UTI Drug Meets Main Goal; Spero Shares Jump

GSK-licensed antibiotic meets goal in late-stage study

SPRO

BioPharma Dive

4 months ago

GSK-licensed antibiotic meets goal in late-stage study

Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee

SPRO

GlobeNewswire

4 months ago

Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee

SPRO

Zacks

4 months ago

Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Misses Revenue Estimates

Spero Therapeutics Announces First Quarter 2025 Operating Results and Provides a Business Update

SPRO

GlobeNewswire

4 months ago

Spero Therapeutics Announces First Quarter 2025 Operating Results and Provides a Business Update

SPRO

GuruFocus.com

4 months ago

Spero Therapeutics Inc (SPRO) Q1 2025: Everything You Need To Know Ahead Of Earnings

Spero Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on Tuesday, May 13, 2025

SPRO

GlobeNewswire

4 months ago

Spero Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on Tuesday, May 13, 2025

Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer

SPRO

GlobeNewswire

5 months ago

Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer

SPRO

Simply Wall St.

6 months ago

We're Keeping An Eye On Spero Therapeutics' (NASDAQ:SPRO) Cash Burn Rate

SPRO

Thomson Reuters StreetEvents

6 months ago

Q4 2024 Spero Therapeutics Inc Earnings Call

SPRO

GuruFocus.com

6 months ago

Spero Therapeutics Inc (SPRO) Q4 2024 Earnings Call Highlights: Navigating Financial Challenges ...

SPRO

Zacks

6 months ago

Spero Therapeutics, Inc. (SPRO) Reports Q4 Loss, Tops Revenue Estimates

Spero Therapeutics Announces Fourth Quarter and Full Year 2024 Operating Results and Provides a Business Update

SPRO

GlobeNewswire

6 months ago

Spero Therapeutics Announces Fourth Quarter and Full Year 2024 Operating Results and Provides a Business Update

Spero Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 27, 2025

SPRO

GlobeNewswire

6 months ago

Spero Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 27, 2025

UPDATE – Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

SPRO

GlobeNewswire

7 months ago

UPDATE – Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

SPRO

GlobeNewswire

7 months ago

Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

SPRO

Zacks

8 months ago

Spero Therapeutics (SPRO) Upgraded to Buy: Here's What You Should Know

SPRO

GlobeNewswire

8 months ago

Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes

Here's Why Arcutis Stock More Than Doubled in Market Value in One Year

SPRO

Zacks

8 months ago

Here's Why Arcutis Stock More Than Doubled in Market Value in One Year

CAPR Stock Up on Completion of Rolling Submission of DMD Drug BLA

SPRO

Zacks

8 months ago

CAPR Stock Up on Completion of Rolling Submission of DMD Drug BLA

Neumora Stock Hits Record Low on Depression Drug Study Failure

SPRO

Zacks

8 months ago

Neumora Stock Hits Record Low on Depression Drug Study Failure

EWTX Stock Rises on Upbeat Data From Rare Muscular Disorder Study

SPRO

Zacks

9 months ago

EWTX Stock Rises on Upbeat Data From Rare Muscular Disorder Study

SPRO

Zacks

9 months ago

Spero Therapeutics (SPRO) Loses -9.32% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday

SPRO

Zacks

9 months ago

Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday

JANX Stock Hits Record High on Prostate Cancer Study Data

SPRO

Zacks

9 months ago

JANX Stock Hits Record High on Prostate Cancer Study Data

PTCT Stock Soars on Licensing Deal With NVS for Huntington's Therapy

SPRO

Zacks

9 months ago

PTCT Stock Soars on Licensing Deal With NVS for Huntington's Therapy

Grifols Stock Declines After Brookfield Drops Buyout Offer

SPRO

Zacks

10 months ago

Grifols Stock Declines After Brookfield Drops Buyout Offer

JAZZ Secures FDA Approval for Ziihera in Biliary Tract Cancer

SPRO

Zacks

10 months ago

JAZZ Secures FDA Approval for Ziihera in Biliary Tract Cancer

Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%

SPRO

Zacks

10 months ago

Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%

FATE Presents Encourgaing Data From Lupus Study, Stock Gains

SPRO

Zacks

10 months ago

FATE Presents Encourgaing Data From Lupus Study, Stock Gains

CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLC

SPRO

Zacks

10 months ago

CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLC

TenNor’s Phase III antibiotic trial meets all primary endpoints

SPRO

Clinical Trials Arena

10 months ago

TenNor’s Phase III antibiotic trial meets all primary endpoints

CHMP Endorses J&J's Rybrevant-Lazcluze Combo for Use in NSCLC

SPRO

Zacks

10 months ago

CHMP Endorses J&J's Rybrevant-Lazcluze Combo for Use in NSCLC

Spero Therapeutics Third Quarter 2024 Earnings: Beats Expectations

SPRO

Simply Wall St.

10 months ago

Spero Therapeutics Third Quarter 2024 Earnings: Beats Expectations

SPRO

Zacks

10 months ago

Spero Therapeutics, Inc. (SPRO) Reports Q3 Loss, Lags Revenue Estimates

Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update

SPRO

GlobeNewswire

10 months ago

Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update

SPRO

GuruFocus.com

10 months ago

What To Expect From Spero Therapeutics Inc (SPRO) Q3 2024 Earnings

Spero Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 14, 2024

SPRO

GlobeNewswire

10 months ago

Spero Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 14, 2024

Equillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings Growth

SPRO

Zacks

10 months ago

Equillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings Growth

Arbutus Biopharma (ABUS) Reports Q3 Loss, Lags Revenue Estimates

SPRO

Zacks

10 months ago

Arbutus Biopharma (ABUS) Reports Q3 Loss, Lags Revenue Estimates

Spero’s stock slides after antibiotic flops in Phase II trial

SPRO

Pharmaceutical Technology

a year ago

Spero’s stock slides after antibiotic flops in Phase II trial

SPRO

MT Newswires

a year ago

Spero Therapeutics Suspends Program for Pulmonary Disease Drug; Plans to Cut Workforce by 39%

Spero Therapeutics Announces SPR720 Phase 2a Interim Results and Provides a Business Update

SPRO

GlobeNewswire

a year ago

Spero Therapeutics Announces SPR720 Phase 2a Interim Results and Provides a Business Update

SPRO

Simply Wall St.

a year ago

Spero Therapeutics, Inc. (NASDAQ:SPRO) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Spero Therapeutics Announces Presentation of SPR719 (Active Moiety of SPR720) In Vitro Data Demonstrating Low Propensity for the Development of Resistance at IDWeek 2024

SPRO

GlobeNewswire

a year ago

Spero Therapeutics Announces Presentation of SPR719 (Active Moiety of SPR720) In Vitro Data Demonstrating Low Propensity for the Development of Resistance at IDWeek 2024

SPRO

MT Newswires

a year ago

Spero Therapeutics Phase 1 Trial of Lung Disease Treatment Backs Further Assessment

Spero Therapeutics Announces Publication of SPR720 Phase 1 Lung Exposure Data in Antimicrobial Agents and Chemotherapy

SPRO

GlobeNewswire

a year ago

Spero Therapeutics Announces Publication of SPR720 Phase 1 Lung Exposure Data in Antimicrobial Agents and Chemotherapy

Spero Therapeutics to Present at Upcoming September Investor Conferences

SPRO

GlobeNewswire

a year ago

Spero Therapeutics to Present at Upcoming September Investor Conferences

Spero Therapeutics Second Quarter 2024 Earnings: Beats Expectations

SPRO

Simply Wall St.

a year ago

Spero Therapeutics Second Quarter 2024 Earnings: Beats Expectations

SPRO

Thomson Reuters StreetEvents

a year ago

Q2 2024 Spero Therapeutics Inc Earnings Call

SPRO

Zacks

a year ago

Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Tops Revenue Estimates

Spero Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on Monday, August 5, 2024

SPRO

GlobeNewswire

a year ago

Spero Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on Monday, August 5, 2024

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SPRO

GlobeNewswire

a year ago

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Denali Therapeutics (DNLI) Moves 5.8% Higher: Will This Strength Last?

SPRO

Zacks

a year ago

Denali Therapeutics (DNLI) Moves 5.8% Higher: Will This Strength Last?

SPRO

GlobeNewswire

a year ago

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference

SPRO

GlobeNewswire

a year ago

Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference

Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update

SPRO

GlobeNewswire

a year ago

Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update

SPRO

Simply Wall St.

a year ago

Shareholders in Spero Therapeutics (NASDAQ:SPRO) are in the red if they invested three years ago

Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024

SPRO

GlobeNewswire

a year ago

Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SPRO

GlobeNewswire

a year ago

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

14 Cheap Penny Stocks to Buy According to Analysts

SPRO

Insider Monkey

a year ago

14 Cheap Penny Stocks to Buy According to Analysts

Spero Therapeutics, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

SPRO

Simply Wall St.

a year ago

Spero Therapeutics, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

SPRO

Insider Monkey

2 years ago

Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2023 Earnings Call Transcript

SPRO

Simply Wall St.

2 years ago

Spero Therapeutics, Inc.'s (NASDAQ:SPRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

SPRO

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Spero Therapeutics Inc Earnings Call

SPRO

Zacks

2 years ago

Spero Therapeutics, Inc. (SPRO) Q4 Earnings and Revenues Top Estimates

Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update

SPRO

GlobeNewswire

2 years ago

Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update

Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024

SPRO

GlobeNewswire

2 years ago

Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024

Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections

SPRO

GlobeNewswire

2 years ago

Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections

Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference

SPRO

GlobeNewswire

2 years ago

Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference

Spero Therapeutics Inc CEO Sath Shukla Sells 75,994 Shares

SPRO

GuruFocus.com

2 years ago

Spero Therapeutics Inc CEO Sath Shukla Sells 75,994 Shares

SPRO

GlobeNewswire

2 years ago

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Quest Resource Holding Corporation's (NASDAQ:QRHC) top owners are retail investors with 36% stake, while 21% is held by institutions

SPRO

Simply Wall St.

2 years ago

Quest Resource Holding Corporation's (NASDAQ:QRHC) top owners are retail investors with 36% stake, while 21% is held by institutions

15 Cash-Rich Penny Stocks Hedge Funds Are Buying

SPRO

Insider Monkey

2 years ago

15 Cash-Rich Penny Stocks Hedge Funds Are Buying

Dow Jones Futures: Microsoft, Apple Lead Earnings Tsunami; What To Do Now

SPRO

Investor's Business Daily

2 years ago

Dow Jones Futures: Microsoft, Apple Lead Earnings Tsunami; What To Do Now

Aquestive Therapeutics (AQST) Increases Despite Market Slip: Here's What You Need to Know

SPRO

Zacks

2 years ago

Aquestive Therapeutics (AQST) Increases Despite Market Slip: Here's What You Need to Know

Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.

SPRO

PR Newswire

2 years ago

Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.

Bright Health Group, Inc.'s (NYSE:BHG) largest shareholders are private equity firms who were rewarded as market cap surged US$33m last week

SPRO

Simply Wall St.

2 years ago

Bright Health Group, Inc.'s (NYSE:BHG) largest shareholders are private equity firms who were rewarded as market cap surged US$33m last week

11 Hyper-Growth Stocks Billionaires Are Loading Up On

SPRO

Insider Monkey

2 years ago

11 Hyper-Growth Stocks Billionaires Are Loading Up On

Xiao-I (NASDAQ: AIXI) and ABB (SIX: ABBN) Forge Strategic Partnership to Drive Industrial Digital Intelligence Advancement with Hua Zang Universal Large Language Model

SPRO

PR Newswire

2 years ago

Xiao-I (NASDAQ: AIXI) and ABB (SIX: ABBN) Forge Strategic Partnership to Drive Industrial Digital Intelligence Advancement with Hua Zang Universal Large Language Model

Virco Manufacturing Corporation (VIRC) Hits Fresh High: Is There Still Room to Run?

SPRO

Zacks

2 years ago

Virco Manufacturing Corporation (VIRC) Hits Fresh High: Is There Still Room to Run?

Spotting Winners: Zevia PBC (NYSE:ZVIA) And Beverages and Alcohol Stocks In Q3

SPRO

StockStory

2 years ago

Spotting Winners: Zevia PBC (NYSE:ZVIA) And Beverages and Alcohol Stocks In Q3

Chuck Royce Increases Stake in Intevac Inc

SPRO

GuruFocus.com

2 years ago

Chuck Royce Increases Stake in Intevac Inc

Red Robin (RRGB) Stock Drops Despite Market Gains: Important Facts to Note

SPRO

Zacks

2 years ago

Red Robin (RRGB) Stock Drops Despite Market Gains: Important Facts to Note

SPRO

Zacks Small Cap Research

2 years ago

AIXI: Initiating Coverage – The AI hype cycle subsides but opportunities and challenges lie ahead in 2024

SelectQuote to Release Fiscal Second Quarter 2024 Earnings on February 7

SPRO

Business Wire

2 years ago

SelectQuote to Release Fiscal Second Quarter 2024 Earnings on February 7

D-Wave Announces 1,200+ Qubit Advantage2™ Prototype in New, Lower-Noise Fabrication Stack, Demonstrating 20x Faster Time-to-Solution on Important Class of Hard Optimization Problems

SPRO

Business Wire

2 years ago

D-Wave Announces 1,200+ Qubit Advantage2™ Prototype in New, Lower-Noise Fabrication Stack, Demonstrating 20x Faster Time-to-Solution on Important Class of Hard Optimization Problems

Unpacking Q3 Earnings: BJ's (NASDAQ:BJRI) In The Context Of Other Sit-Down Dining Stocks

SPRO

StockStory

2 years ago

Unpacking Q3 Earnings: BJ's (NASDAQ:BJRI) In The Context Of Other Sit-Down Dining Stocks

SPRO

Simply Wall St.

2 years ago

Spero Therapeutics, Inc. (NASDAQ:SPRO): Are Analysts Optimistic?

SPRO

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Five Point Holdings LLC Earnings Call

United States Food & Drug Administration (FDA) Grants Mesoblast Rare Pediatric Disease Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease

SPRO

GlobeNewswire

2 years ago

United States Food & Drug Administration (FDA) Grants Mesoblast Rare Pediatric Disease Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease

Five Point Holdings LLC Reports Robust Earnings Amid Economic Challenges

SPRO

GuruFocus.com

2 years ago

Five Point Holdings LLC Reports Robust Earnings Amid Economic Challenges

Bright Health rebrands as NeueHealth, distances itself from insurance portfolio

SPRO

Healthcare Dive

2 years ago

Bright Health rebrands as NeueHealth, distances itself from insurance portfolio

4 Stocks to Buy as Manufacturing Activity Makes Steady Progress

SPRO

Zacks

2 years ago

4 Stocks to Buy as Manufacturing Activity Makes Steady Progress

American Lithium Announces Financial and Operating Highlights for Third Quarter Ended November 30, 2023

SPRO

GlobeNewswire

2 years ago

Latest Spero Therapeutics Inc. (SPRO) News on September 16, 2025

Share on Social Networks: